Associated Papers
DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers.
Sun R et al.
Proceedings of the National Academy of Sciences of the United States of America, 2025
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies.
Frank S et al.
Biorxiv : the Preprint Server for Biology, 2025
39071291 (PubMed )
Supplement: media-1.xlsx › SU2C-I
Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.
Chou J et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
Select a paper to view details